Last reviewed · How we verify
NCT07299760
Analgesic Efficacy of Parasternal Block Versus Parasternal Plus Serratus Anterior Plane Block After Coronary Bypass Surgery
NA trial testing parasternal block in Coronary Artery Bypass Grafting in 72 participants. Completed in 1 January 2026.
1 December 2025
Quick facts
| Lead sponsor | Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 72 |
| Start date | 1 September 2025 |
| Primary completion | 1 December 2025 |
| Estimated completion | 1 January 2026 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- parasternal block — full drug profile →
- parasternal block + serratus anterior plane block
Conditions studied
- Coronary Artery Bypass Grafting — all drugs for Coronary Artery Bypass Grafting →
Sponsor
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Who can join
Adults 18 to 85, any sex, with Coronary Artery Bypass Grafting. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This single-centre randomized clinical trial will compare two regional anaesthesia techniques for postoperative pain control in adult patients undergoing elective coronary artery bypass grafting (CABG) with sternotomy. All patients will receive a bilateral parasternal block as part of routine multimodal analgesia. Patients will be randomized to receive either parasternal block alone or a combination of parasternal block and serratus anterior plane block. The primary objective is to evaluate whether adding a serratus anterior plane block improves postoperative pain scores compared with parasternal block alone. Secondary objectives include comparing opioid consumption, need for rescue analgesics, opioid-related side effects, and length of stay in the intensive care unit and hospital.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07299760
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of parasternal block
Trials testing the same drug.
- NCT06608290 — Paraesternal Blockade and Lactate Serum Levels in Patients With Cardiac Surgery. · Phase 3 · completed
Other recruiting trials for Coronary Artery Bypass Grafting
Currently open trials in the same condition.
- NCT07116733 — Desflurane vs. Propofol for Cardiac Anesthesia · Phase 3 · recruiting
- NCT07172620 — Safety and Effectiveness of No-touch Technique for Ascending Aorta in MICS-CABG · recruiting
- NCT06981390 — Ticagrelor-Based Dual Antiplatelet Therapy Duration in CABG · NA · recruiting
- NCT06787651 — Comparison of RIMA-SVG and Ao-SVG Techniques in Coronary Artery Bypass Grafting · NA · active not recruiting
- NCT06798714 — The Effect of Colchicine on the Occurrence of Atrial Fibrillation After Cardiac Surgery · Phase 4 · recruiting
Other Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital trials
Trials by the same sponsor.
- NCT07394816 — Can Ultrasound-Guided Fascial Plane Blocks Reduce Postoperative Pulmonary Complications After Major Abdominal Surgery? · not yet recruiting
- NCT07509697 — Artificial Intelligence-Based Evaluation of Chest X-Rays in Ventilator-Associated Pneumonia · completed
- NCT07440095 — Mortality Predictors in Patients 80+ After Major Abdominal Surgery: Role of Frailty and Physiological Reserve · not yet recruiting
- NCT07392086 — Comparison of FCV and VCV in One-Lung Ventilation · recruiting
- NCT07325617 — Tracking AI/LLM Literacy and Knowledge in Urology Outpatients (TALK-U) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07299760 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
- Last refreshed: 13 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07299760.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing